Driving clinical study efficiency by using a productivity breakdown model: comparative evaluation of a global clinical study and a similar Japanese study.


WHAT IS KNOWN AND OBJECTIVE A fundamental management imperative of pharmaceutical companies is to contain surging costs of developing and launching drugs globally. Clinical studies are a research and development (R&D) cost driver. The objective of this study was to develop a productivity breakdown model, or a key performance indicator (KPI) tree, for an… (More)
DOI: 10.1111/j.1365-2710.2010.01158.x


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.